The novel coronavirus SARS-CoV-2 emerged as a human pathogen in China at the end of 2019 and has since spread across the globe. Understanding the structure and function of this virus is essential to target vaccines and therapies to tackle the COVID-19 disease.
Click here to discover the structure and function of SARS-CoV-2 cell entry at a glance with Abcam succinct guide.
Multiplicom is proud to launch Clarigo™, a new CE-IVD1 non-invasive prenatal test (NIPT). This highly accurate blood test will enable genetic analysis laboratories to detect the presence or absence of major chromosomal abnormalities such as trisomy 21 (Down’s syndrome), 18 (Edwards’ syndrome) and 13 (Patau syndrome), in the fetus, as early as in the first trimester of pregnancy by analysis of the fetus’s DNA in the maternal blood.
October 22, 2015 More +
There is more to hypoxia than just HIF-1 alpha activation. Find some of its downstream targets and which tools are available to study them.
January 03, 2017 More +
Call us on: + 961 1 39 66 77
